Roger Jeffs, Director at Axsome Therapeutics, Inc. (AXSM), sold 26,928 shares at $123.68 ($3.3M) on 2025-09-02, disclosed to the SEC on 2025-09-02.
Scheduled sale ($3.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $123.68 | 13,464 | $1.7M | 50.0% |
| 2 | $123.68 | 13,464 | $1.7M | 50.0% |
| Total | $123.68 avg | 26,928 | $3.3M | 100% |
| Filing → |
| LQDA | SELL | 2026-05-28 | $400K | — | Filing → |
| LQDA | SELL | 2026-05-26 | $4.6M | — | Filing → |
| LQDA | SELL | 2026-05-20 | $4.4M | — | Filing → |